戻る
Marvel Biosciences Corp (MBCOF)価格
MBCOF 株価推移チャート
MBCOF 収入
Marvel Biosciences Corp
$0.1
4.93%
$0
終値： Jan 16, 16:00:00 GMT-5
$0.1
0%
$0
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$0.0953
始値
$0.1001
当日レンジ
$0.1 - $0.1001
52週レンジ
$0.046 - $0.241
取引高
5.0K
平均取引高
13.6K
1株当たり利益(TTM)
-0.04
配当利回り
--
時価総額
$5.8M
MBCOFとは何ですか？
Marvel Biosciences Corp. is a biotechnology company that utilizes a drug redevelopment approach to drug development. The company is headquartered in Calgary, Alberta. The company went IPO on 2019-02-28. The firm develops new synthetic chemical derivatives of the original approved drug for the new disease indication. The company has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs that inhibit the A2a adenosine receptor with application to neurological diseases (depression and anxiety, Alzheimer's, attention deficit hyperactivity disorder (ADHD)), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. The firm's lead compound, MB-204, is a fluorinated derivative of Istradefylline. The firm is engaged in developing MB-204 for diseases other than Parkinson's disease, specifically depression, Alzheimer’s Disease and liver fibrosis due to non-alcoholic steatohepatitis (NASH). Its wholly owned subsidiary is Marvel Biotechnology Inc.